Suggestions
Matthew Diamond
Chief Medical Officer for Digital Health at FDA
Matthew Diamond, MD, PhD is the Chief Medical Officer for Digital Health at the FDA's Center for Devices and Radiological Health (CDRH).1 In this role, he serves as the senior clinical expert for digital health medical devices, providing clinical leadership for policy development on digital health technologies, including artificial intelligence-enabled medical devices.1
Dr. Diamond's career highlights include:
-
Education: MD and PhD (biophysics) from Mount Sinai School of Medicine12
-
Current positions:
-
Previous roles:
- Medical Officer for Digital Health at FDA (2018-2020)2
- Chief Medical Officer at Nokia Technologies (2017-2018)2
- Vice Chair of the Consumer Technology Association Health & Fitness Technology Board (2017-2018)2
- Medical Director at Fossil Group, Inc. and Misfit Wearables2
- Staff Physician at the Harkness Center for Dance Injuries, NYU Hospital for Joint Diseases (2013-2018)2
Dr. Diamond is board certified in rehabilitation medicine and certified in medical acupuncture.1 He has extensive experience in sports medicine, rehabilitation, and digital health technologies. In his FDA role, he represents the agency in national and international digital health initiatives, including chairing the International Medical Device Regulators Forum (IMDRF) Artificial Intelligence Working Group.1
Highlights
Very proud of FDA team members' collaborative, innovative approach to promoting the safety and effectiveness of medical products that incorporate or are developed using Artificial Intelligence -- this paper jointly issued by FDA's Drug, Device, and Biologic Centers and the Office of Combination Products builds on the Agency's longstanding commitment in this area and focuses on: (1) Fostering Collaboration to Safeguard Public Health; (2) Advancing the Development of Regulatory Approaches that Support Innovation; (3) Promoting the Development of Standards, Guidelines, Best Practices, and Tools for the Medical Product Life Cycle; and (4) Supporting Research Related to the Evaluation and Monitoring of AI Performance.
Your input is needed on using digital health technologies in research! Considerations for informed consent, with sample language, available for feedback -- NIH RFI now live with response requested by Dec 12:
